Zobrazeno 1 - 10
of 26
pro vyhledávání: '"Yasukatsu, Yuda"'
Autor:
Lucia S. Yoshida, Tomie Kawada, Kaoru Irie, Yasukatsu Yuda, Toshiyuki Himi, Fumihiko Ikemoto, Hiromi Takano-Ohmuro
Publikováno v:
Journal of Pharmacological Sciences, Vol 112, Iss 3, Pp 343-351 (2010)
Recently, an isomeric mixture of herbal anti-inflammatory naphthoquinones shikonin and alkannin, and their derivatives, have been found to impair cellular responses involving nitric oxide (NO) and NO synthesis, like the acetylcholine-induced relaxati
Externí odkaz:
https://doaj.org/article/221b8cf8d9ce4e4688231a4d8d7a3573
Publikováno v:
Risk Management and Healthcare Policy
Kaori Nomura,1 Yuki Kitagawa,2 Yasukatsu Yuda,2 Hiromi Takano-Ohmuro2 1Division of Molecular Epidemiology, Jikei University School of Medicine, 2Faculty of Pharmacy, Musashino University, Shinmachi, Tokyo, Japan Objectives: Japan has actively reclass
Autor:
Hirokazu Kawagishi, Hiromi Takano-Ohmuro, Lucia Satiko Yoshida, Yasukatsu Yuda, Naokazu Morishita, Kimiko Kazumura, Tomohito Kakegawa, Hiroshi Tsuchiya, Akiko Hara
Publikováno v:
Journal of Clinical Biochemistry and Nutrition. 59:1-9
Shikonin, an anti-inflammatory compound of "Shikon", inhibits the neutrophil superoxide (O2 (•-)) generation by NADPH oxidase 2 (Nox2); however, the mechanisms of how shikonin affects Nox2 activity remained unclear. We aimed to elucidate the relati
Publikováno v:
Journal of natural medicines. 71(4)
We aimed to find candidate molecules possibly involved in the anti-inflammatory activity of shikonin (active compound of "Shikon") by analyzing its effects on gene expression of lipopolysaccharide (LPS)-treated THP-1 macrophages. Polysome-associated
Publikováno v:
Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan. 136(2)
Kampo medicines must be used according to an individual's physical characteristics and symptoms to avoid lack of efficacy, adverse reactions or interactions with other drugs. As category-2 over-the-counter drugs (OTCs), Kampo OTCs are not targets of
Autor:
Kimiko, Kazumura, Lucia Satiko, Yoshida, Akiko, Hara, Hiroshi, Tsuchiya, Naokazu, Morishita, Hirokazu, Kawagishi, Tomohito, Kakegawa, Yasukatsu, Yuda, Hiromi, Takano-Ohmuro
Publikováno v:
Journal of Clinical Biochemistry and Nutrition
Shikonin, an anti-inflammatory compound of "Shikon", inhibits the neutrophil superoxide (O2 (•-)) generation by NADPH oxidase 2 (Nox2); however, the mechanisms of how shikonin affects Nox2 activity remained unclear. We aimed to elucidate the relati
Autor:
Hiroyuki Sasaki, Tsuneya Ohno, Yuzuru Matsuda, Yasukatsu Yuda, Yoshiaki Nonomura, Mariko Nakamura
Publikováno v:
Proceedings of the National Academy of Sciences. 92:2026-2030
We examined the potential role of myosin and actin in the release of human immunodeficiency virus type 1 (HIV-1) from infected cells. Wortmannin (100 nM to 5 microM), an effective inhibitor of myosin light chain kinase, blocked the release of HIV-1 f
Autor:
Kaoru Irie, Tomie Kawada, Lucia S. Yoshida, Yasukatsu Yuda, Hiromi Takano-Ohmuro, Fumihiko Ikemoto, Toshiyuki Himi
Publikováno v:
Journal of Pharmacological Sciences, Vol 112, Iss 3, Pp 343-351 (2010)
Recently, an isomeric mixture of herbal anti-inflammatory naphthoquinones shikonin and alkannin, and their derivatives, have been found to impair cellular responses involving nitric oxide (NO) and NO synthesis, like the acetylcholine-induced relaxati
Publikováno v:
Chemical and Pharmaceutical Bulletin. 39:1075-1077
Effects of non-steroidal anti-inflammatory drugs (NSAID: amfenac sodium, diclofenac sodium, indomethacin and ketoprofen) on the generation of superoxide anion (O2-) by isolated rat polymorphonuclear leukocytes (PMN) were studied spectrophotometricall
Publikováno v:
Risk Management & Healthcare Policy; Jul2016, Vol. 9, p173-183, 11p